PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existing alternatives in the United States. Amadix becomes the first European company to announce this recognition for early detection of colorectal cancer. MADRID, Jan. 23, 2024 /PRNewswire/ — Amadix, a Spanish biotech company, announced today that… Continue reading FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
Category: Newswire
Leopard Imaging to Host 2024 IEEE P2020 Annual Meeting at its Headquarters in Fremont, California
Formed in 2016, the IEEE P2020 working group identified a significant gap in existing imaging standards for automotive applications. With the increasing integration of cameras into modern vehicles, often serving as crucial components for safety systems, a consistent approach to measuring image quality became imperative. Although various standards such as EMVA1288, ISO12233, ISO15739, ISO18844, and… Continue reading Leopard Imaging to Host 2024 IEEE P2020 Annual Meeting at its Headquarters in Fremont, California
FDA vergibt präventivem Screening-Bluttest für Dickdarmkrebs von Amadix die Bezeichnung „bahnbrechend”
PreveCol®, ein Bluttest zur Krebsdiagnose, der wirksamer als bereits existierende Alternativen in den USA ist, wurde in den USA für die Erkennung von präkanzerösen Läsionen anerkannt. Amadix ist das erste europäische Unternehmen, dessen Methode zur Früherkennung von Dickdarmkrebs die Bezeichnung „bahnbrechend” erhält. MADRID, 23. Januar 2024 /PRNewswire/ — Amadix, ein spanisches Biotech-Unternehmen, hat heute bekanntgegeben, dass… Continue reading FDA vergibt präventivem Screening-Bluttest für Dickdarmkrebs von Amadix die Bezeichnung „bahnbrechend”
La FDA accorde la désignation de dispositif révolutionnaire au test sanguin de dépistage préventif d’Amadix pour le cancer colorectal
PreveCol®, un test sanguin pour le diagnostic oncologique, a obtenu la reconnaissance américaine pour son efficacité dans la détection des lésions précancéreuses par rapport aux alternatives existantes aux États-Unis. Amadix devient la première entreprise européenne à annoncer cette reconnaissance pour la détection précoce du cancer colorectal. MADRID, 23 janvier 2024 /PRNewswire/ — Amadix, une société de… Continue reading La FDA accorde la désignation de dispositif révolutionnaire au test sanguin de dépistage préventif d’Amadix pour le cancer colorectal
Time is Running Out to Close the Widening Skills Gap, Reveals New Research from TrueBlue’s PeopleScout in Partnership with Spotted Zebra
Study reveals 90 percent of HR leaders believe that half of their workforce will need to be reskilled in the next five years CHICAGO, Jan. 23, 2024 /PRNewswire/ — TrueBlue (NYSE: TBI), a leading provider of specialized workforce solutions, today announced the results of a comprehensive study from leading recruitment process outsourcing provider PeopleScout, a… Continue reading Time is Running Out to Close the Widening Skills Gap, Reveals New Research from TrueBlue’s PeopleScout in Partnership with Spotted Zebra
Carbon Nanotubes Global Market Report 2024-2034: Developments in Conductive Films, Fuel Cells, Sensors & Drug Delivery
DUBLIN, Jan. 23, 2024 /PRNewswire/ — The “Global Market for Carbon Nanotubes 2024-2034” report has been added to ResearchAndMarkets.com’s offering. The global market of carbon nanotubes is generally segmented by Multi-Walled Carbon Nanotubes (MWCNT), Single-Walled Carbon Nanotubes (SWCNT) and others (DWCNT, FWCNT). For today, MWCNT comprise the biggest share in terms of sales volumes, and production capacities.… Continue reading Carbon Nanotubes Global Market Report 2024-2034: Developments in Conductive Films, Fuel Cells, Sensors & Drug Delivery
La FDA otorga la designación de dispositivo innovador al análisis de sangre de Amadix
– La FDA otorga la designación de dispositivo innovador al análisis de sangre de detección preventiva del cáncer colorrectal de Amadix PreveCol®, un análisis de sangre para diagnóstico oncológico, obtiene el reconocimiento estadounidense por su eficacia en la detección de lesiones precancerosas frente a las alternativas existentes en Estados Unidos. Amadix se convierte en la… Continue reading La FDA otorga la designación de dispositivo innovador al análisis de sangre de Amadix
Baird Medical Performs First Thyroid Microwave Ablation Procedure in the United States
FRISCO, Texas, Jan. 23, 2024 /PRNewswire/ — Baird Medical Devices, Inc. (“Baird Medical” or the “Company”), a leading microwave ablation (“MWA”) medical device developer and provider in China and the United States, today announced that it has performed its first thyroid MWA procedure in the United States since obtaining registration clearance from the U.S. Food… Continue reading Baird Medical Performs First Thyroid Microwave Ablation Procedure in the United States
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existing alternatives in the United States. Amadix becomes the first European company to announce this recognition for early detection of colorectal cancer. MADRID, Jan. 23, 2024 /PRNewswire/ — Amadix, a Spanish biotech company, announced today that… Continue reading FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
Bybit’s ByBUIDLERs Program: Shaping the Next Wave of Crypto Influencers
DUBAI, UAE, Jan. 23, 2024 /PRNewswire/ — Bybit, the world’s third largest crypto exchange by volume, is thrilled to announce the launch of the second generation of its innovative ByBUIDLERs Program. Building on the resounding success of its original program, Bybit aims to transform more individuals into influential content creators and community influencers in the… Continue reading Bybit’s ByBUIDLERs Program: Shaping the Next Wave of Crypto Influencers